Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Delstrigo (doravirine/lamivudine/tenofovir disoproxil by Quarter
Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate — HIV-1) — International reported growth YoY (%) (%)
Merck Delstrigo (doravirine/lamivudine/tenofovir disoproxil: 27.0% in Q2 2026, down 28.0 pts from a year earlier.
Where the Q2 2026 figure comes from
“|| Delstrigo | 101 | 83 | 21 | 13 | 14 | -7 | 88 | 70 | 27”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Table 3a / 3b Product Sales.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate — HIV-1) — International reported growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 27.0% | -28.0 pts | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 19.0% | -11.0 pts | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q3 2025 | Sep 30, 2025 | 29.0% | +6.0 pts | Form 8-K (tm2529620d1_ex99-1.htm, filed 2025-10-30) ↗ |
| Q2 2025 | Jun 30, 2025 | 55.0% | +34.0 pts | Form 8-K (tm2521736d1_ex99-1.htm, filed 2025-07-29) ↗ |
| Q1 2025 | Mar 31, 2025 | 17.0% | -17.0 pts | Form 8-K (tm2512885d1_ex99-1.htm, filed 2025-04-24) ↗ |
| Q4 2024 | Dec 31, 2024 | 30.0% | – | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| Q3 2024 | Sep 30, 2024 | 23.0% | – | Form 8-K (tm2426878d1_ex99-1.htm, filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 21.0% | – | Form 8-K (tm2420272d1_ex99-1.htm, filed 2024-07-30) ↗ |
| Q1 2024 | Mar 31, 2024 | 34.0% | – | Form 8-K (tm2412490d1_ex99-1.htm, filed 2024-04-25) ↗ |
Cite this data
StockData. (2026). Merck Delstrigo (doravirine/lamivudine/tenofovir disoproxil (%), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-delstrigo-intl-nom-yoy
See every metric in the Merck KPI table. Data updated Oct 26, 2026.